Shen Angela K, Sobzcyk Elizabeth, Buchanan Anna, Wu Lauren, Duggan-Goldstein Sarah
National Vaccine Program Office US Department of Health and Human Services, Washington, DC, USA.
Hum Vaccin. 2011 Jan 1;7(1):12-8. doi: 10.4161/hv.7.1.13949.
At the 2nd National Immunization Congress held in Chicago, IL, from August 31-September 2, 2010, partners from government, provider groups, academia, and manufacturers gathered to discuss the progress made and the future of financing child, adolescent, and adult vaccines. The meeting is a continuation of a solution-oriented vaccine financing dialogue held in February 2007 at the 1st Immunization Congress. The need for this forum arose from concerns that increased costs of immunization could hinder the ability of current financing and delivery systems to maintain access without financial barriers. Preventive care and additional financial coverage for vaccines are key points in federal health reform but some populations, especially adolescents and adults, could continue to experience challenges in accessing vaccines. Congress participants discussed adequate reimbursement in the public and private sectors for vaccine delivery and the potential financial resources, data, and infrastructure needed to increase vaccine uptake in the US. Participants agreed that partners from all sectors--manufacturers, providers, public health, employers, payors, insurers, and consumers--will collectively need to leverage their efforts to address financial gaps not covered by health care reform law to ensure the preventive benefits of vaccines are fully realized for all Americans.
2010年8月31日至9月2日，在伊利诺伊州芝加哥市举行的第二届全国免疫大会上，来自政府、医疗服务提供团体、学术界和制造商的合作伙伴齐聚一堂，讨论在儿童、青少年和成人疫苗融资方面取得的进展以及未来发展方向。本次会议延续了2007年2月在第一届免疫大会上举行的以解决问题为导向的疫苗融资对话。设立这个论坛的必要性源于人们担心免疫接种成本增加可能会阻碍当前融资和供应系统在无经济障碍情况下维持疫苗可及性的能力。预防性护理和疫苗的额外医保覆盖是联邦医疗改革的关键点，但一些人群，尤其是青少年和成年人，在获取疫苗方面可能仍会面临挑战。大会参与者讨论了公共和私营部门为疫苗接种提供的充足报销以及在美国提高疫苗接种率所需的潜在财政资源、数据和基础设施。与会者一致认为，所有部门的合作伙伴——制造商、医疗服务提供者、公共卫生机构、雇主、付款方、保险公司和消费者——需要共同努力，填补医疗改革法律未涵盖的资金缺口，以确保所有美国人都能充分享受到疫苗的预防益处。
